Makoto Kakutani
Takatsuki, 5691125, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Intrajejunal infusion of 2-monoacylglycerol reduced food intake without inducing diarrhea in rats.
Journal: Journal of pharmacological sciences
Published: July 09, 2015
JTT-553, a novel Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 inhibitor, improves glucose metabolism in diet-induced obesity and genetic T2DM mice.
Journal: Journal of pharmacological sciences
Published: June 16, 2015
JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models.
Journal: Journal of pharmacological sciences
Published: June 08, 2015
JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis.
Journal: Journal of pharmacological sciences
Published: April 09, 2015
Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Journal: Biological & pharmaceutical bulletin
Published: March 10, 2015
JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity.
Journal: European journal of pharmacology
Published: December 11, 2014
Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats.
Journal: Journal of pharmacological sciences
Published: September 25, 2014
JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, reduces food preference for fat.
Journal: Journal of diabetes research
Published: March 20, 2014
JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats.
Journal: Journal of diabetes research
Published: March 17, 2014
Combination therapy of an intestine-specific inhibitor of microsomal triglyceride transfer protein and peroxisome proliferator-activated receptor γ agonist in diabetic rat.
Journal: Journal of diabetes research
Published: January 07, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026